GeoVax Labs Statistics
Total Valuation
GeoVax Labs has a market cap or net worth of $12.98 million. The enterprise value is $12.22 million.
| Market Cap | 12.98M |
| Enterprise Value | 12.22M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GeoVax Labs has 4.64 million shares outstanding. The number of shares has increased by 34.81% in one year.
| Shares Outstanding | 4.64M |
| Shares Change (YoY) | +34.81% |
| Shares Change (QoQ) | +19.51% |
| Owned by Insiders (%) | 0.79% |
| Owned by Institutions (%) | 5.19% |
| Float | 2.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.63 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 239.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87, with zero debt.
| Current Ratio | 0.87 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -346.20% and return on invested capital (ROIC) is -52,243.95%.
| Return on Equity (ROE) | -346.20% |
| Return on Assets (ROA) | -221.80% |
| Return on Capital (ROIC) | -52,243.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.63M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.19% in the last 52 weeks. The beta is 3.10, so GeoVax Labs's price volatility has been higher than the market average.
| Beta (5Y) | 3.10 |
| 52-Week Price Change | -67.19% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 3.88 |
| Relative Strength Index (RSI) | 53.34 |
| Average Volume (20 Days) | 6,989,009 |
Short Selling Information
The latest short interest is 1.26 million, so 27.10% of the outstanding shares have been sold short.
| Short Interest | 1.26M |
| Short Previous Month | 109,014 |
| Short % of Shares Out | 27.10% |
| Short % of Float | 54.88% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.36M |
| Pretax Income | -27.78M |
| Net Income | -27.78M |
| EBITDA | -27.70M |
| EBIT | -27.78M |
| Earnings Per Share (EPS) | -$14.51 |
Balance Sheet
The company has $768,859 in cash and no debt, giving a net cash position of $768,859 or $0.17 per share.
| Cash & Cash Equivalents | 768,859 |
| Total Debt | n/a |
| Net Cash | 768,859 |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 54,275 |
| Book Value Per Share | 0.01 |
| Working Capital | -441,529 |
Cash Flow
In the last 12 months, operating cash flow was -$27.09 million and capital expenditures -$48,946, giving a free cash flow of -$27.14 million.
| Operating Cash Flow | -27.09M |
| Capital Expenditures | -48,946 |
| Free Cash Flow | -27.14M |
| FCF Per Share | -$11.47 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GeoVax Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.81% |
| Shareholder Yield | -34.81% |
| Earnings Yield | -213.94% |
| FCF Yield | -209.04% |
Analyst Forecast
The average price target for GeoVax Labs is $14.00, which is 400.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 400.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 31, 2024. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |